Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
666-03-001 ISMRM Abstract

Quantitative UTE MRI for Demyelination Detection in Alzheimer's Disease Using a Transgenic Mouse Model

Primary: Preclinical Animal & in vitro MR - Biomarkers
Secondary: Preclinical Animal & in vitro MR - Small Animals
666-03-001 · Neuro-Biomarkers · Thursday, 14 May, 1:40 PM–2:35 PM · Digital Posters Row G
Keywords: Alzheimer's Disease Quantitative techniques Transgenic mice Demyelination 3D Ultrashort Echo Time MRI
Accepted
Jiyo S Athertya1, Jiaji Wang2,3, Amanda Patel4, Ethan Zhenyi Zhou1, Qingbo Tang5,6, Xin Cheng5, Eric Y Chang7, Shanshan Wang7, Yajun Ma1, Brian Head7, Jiang Du5,6
1University of California, San Diego, United States of America
2Department of Radiology, University of California, San Diego, United States of America
3Department of Radiology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China
4University of California, Santa Barbara, United States of America
5University of California, Berkeley, United States of America
6Radiology Service, VA San Diego Healthcare System, La Jolla, California, San Diego, United States of America
7VA San Diego Healthcare System, San Diego, United States of America
Presenting Author: Soo Hyun Shin

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Huang Z, Jordan JD, Zhang Q. Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities. Aging Dis. 2024 Apr 1;15(2):698-713. doi: 10.14336/AD.2023.0628. PMID: 37548935; PMCID: PMC10917545. [doi] [pmid]
2. Bouhrara M, Reiter DA, Bergeron CM, Zukley LM, Ferrucci L, Resnick SM, Spencer RG. Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific MRI measure of myelin content. Alzheimers Dement 2018; 14:998-1004.
3. Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes. Acta Neuropathologica Communications 2018; 6:22.
4. Sinha K, Karimi-Abdolrezaee S, Velumian AA, Fehlings MG. Functional changes in genetically demyelinated spinal cord axons of shiverer mice role of juxtaparanodal Kv1 family K+ channels. Journal of Neurophysiology 2006; 95:1683-1695.
5. Lee Y, Morrison BM, Li Y., et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012; 487:443-448.
6. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001; 294:1731-1735.
7. Huang Z, Zhang Y, Zou P, Zong X, Zhang Q. Myelin dysfunction in aging and brain disorders: mechanisms and therapeutic opportunities. Mol Neurodegener. 2025 Jun 15;20(1):69. doi: 10.1186/s13024-025-00861-w. PMID: 40518508; PMCID: PMC12168329. [doi] [pmid]
8. Papuć E, Rejdak K. The role of myelin damage in Alzheimer's disease pathology. Arch Med Sci. 2018 Aug 28;16(2):345-351. doi: 10.5114/aoms.2018.76863. PMID: 32190145; PMCID: PMC7069444.Maitre, M., Jeltsch-David, H., Okechukwu, N.G. et al. Myelin in Alzheimer’s disease: culprit or bystander?. acta neuropathol commun 11, 56 (2023). https://doi.org/10.1186/s40478-023-01554-5 [doi] [pmid]
9. Gao, C., Jiang, J., Tan, Y. et al. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Sig Transduct Target Ther 8, 359 (2023). https://doi.org/10.1038/s41392-023-01588-0 [doi]
10. Chouliaras, L., O’Brien, J.T. The use of neuroimaging techniques in the early and differential diagnosis of dementia. Mol Psychiatry 28, 4084–4097 (2023). https://doi.org/10.1038/s41380-023-02215-8 [doi]
11. Ma YJ, Jang H, Chang EY, et al. Ultrashort echo time (UTE) magnetic resonance imaging of myelin: Technical developments and challenges. Quant. Imaging Med. Surg. 2020;10:1186–1203 doi: 10.21037/QIMS-20-541. [doi]
12. Ma Y, Jang H, Jerban S, Chang EY, Chung CB, Bydder GM, Du J. Making the invisible visible-ultrashort echo time magnetic resonance imaging: Technical developments and applications. Appl Phys Rev. 2022 Dec;9(4):041303. doi: 10.1063/5.0086459. PMID: 36467869; PMCID: PMC9677812. [doi] [pmid]
13. Athertya JS, Daskareh M, Shin SH, Wang J, Lo J, Ma Y. Brain short T2 component imaging using double adiabatic inversion recovery prepared ultrashort Echo time (DIR-UTE) sequence. Neuroimage. 2025 Aug 1;316:121315. doi: 10.1016/j.neuroimage.2025.121315. Epub 2025 Jun 6. PMID: 40484328. [doi] [pmid]
14. Ma YJ, Jang H, Wei Z, Cai Z, Xue Y, Lee RR, Chang EY, Bydder GM, Corey-Bloom J, Du J. Myelin Imaging in Human Brain Using a Short Repetition Time Adiabatic Inversion Recovery Prepared Ultrashort Echo Time (STAIR-UTE) MRI Sequence in Multiple Sclerosis. Radiology. 2020 Nov;297(2):392-404. doi: 10.1148/radiol.2020200425. Epub 2020 Aug 11. PMID: 32779970 [doi] [pmid]
15. Ma YJ, Jang H, Wei Z, Wu M, Chang EY, Corey-Bloom J, Bydder GM, Du J. Brain ultrashort T2 component imaging using a short TR adiabatic inversion recovery prepared dual-echo ultrashort TE sequence with complex echo subtraction (STAIR-dUTE-ES). J Magn Reson. 2021 Feb;323:106898. doi: 10.1016/j.jmr.2020.106898. Epub 2020 Dec 28. PMID: 33429170 [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/666-03-001